Experimental stem cell infusion tested for rare nerve disease
NCT ID NCT06218134
First seen Dec 29, 2025 · Last updated Apr 30, 2026 · Updated 18 times
Summary
This study tested a one-time intravenous dose of stem cells (EN001) in 3 adults with Charcot-Marie-Tooth disease type 1E, a severe inherited nerve disorder that causes muscle weakness, loss of sensation, and often wheelchair dependence. The main goal was to check safety, with early signs of benefit also measured. Previous studies in a related type (CMT1A) found the treatment safe with only mild, temporary side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE, TYPE 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SMC
Seoul, Gangnam-gu, 06351, South Korea
Conditions
Explore the condition pages connected to this study.